Serin, K. R. Et Al. 2021. Clinical utility of tensin 2 levels as a diagnostic and prognostic biomarker in breast cancer. Acta Medica Mediterranea , vol.37, no.1 , 553-558.

Serin, K. R., Ucuncu, Z., Kemal Temel, M., BADEMLER, S., Soydinç, H. O., KARANLIK, H., ... KARABULUT, S.(2021). Clinical utility of tensin 2 levels as a diagnostic and prognostic biomarker in breast cancer. Acta Medica Mediterranea , vol.37, no.1, 553-558.

Serin, Kurşat Et Al. "Clinical utility of tensin 2 levels as a diagnostic and prognostic biomarker in breast cancer," Acta Medica Mediterranea , vol.37, no.1, 553-558, 2021

Serin, Kurşat R. Et Al. "Clinical utility of tensin 2 levels as a diagnostic and prognostic biomarker in breast cancer." Acta Medica Mediterranea , vol.37, no.1, pp.553-558, 2021

Serin, K. R. Et Al. (2021) . "Clinical utility of tensin 2 levels as a diagnostic and prognostic biomarker in breast cancer." Acta Medica Mediterranea , vol.37, no.1, pp.553-558.

@article{article, author={Kurşat Rahmi Serin Et Al. }, title={Clinical utility of tensin 2 levels as a diagnostic and prognostic biomarker in breast cancer}, journal={Acta Medica Mediterranea}, year=2021, pages={553-558} }